Adagene

IPO

Public · Suzhou, China · Founded 2011 · $180.0M raised

Headquarters
Suzhou
Employees
51–200
Founded
2011
Business Model
B2B
Total Funding
$180.0M
Last Round
$25.0M Corporate RoundJul 2025
Rounds
5
Type
Public

About

Adagene is a Nasdaq-listed, platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based cancer immunotherapies. Powered by its proprietary SAFEbody and NEObody technologies, Adagene designs antibodies with superior safety, tolerability, and efficacy profiles. The company combines computational biology and AI to identify candidates with novel mechanisms of action addressing unmet patient needs.

Summary

Adagene is an Artificial Intelligence company based in Suzhou, China, founded in 2011. It has raised $180.0M in total across 5 rounds, most recently a $25.0M Corporate Round round in Jul 2025. Investors include F-Prime Capital, Sanofi Ventures and General Atlantic.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundJul 2025
$25.0M

Sign up to see all 6 rounds

Series A through Corporate Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Adagene on Indexed.vc
<a href="https://indexed.vc/companies/adagene"><img src="https://indexed.vc/api/badge/company/adagene" alt="Adagene on Indexed.vc" width="260" height="76" /></a>